Sickle Cell Disease and Risk of Venous Thromboembolism: A Systematic Review
Adolescência e Saúde · 03.11.2026 · 1239-1253
DOI: 10.67440/ahj.vi.3148 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Adolescência e Saúde, online erschienen am 03.11.2026. Verfasst von Nader Awad Alanazi und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) is associated with a prothrombotic state, but clinical venous thromboembolism (VTE) estimates differ markedly between population-based, inpatient, paediatric, maternity and referral-care settings.
Objective
To critically synthesise evidence on deep vein thrombosis (DVT), pulmonary embolism (PE) and VTE in SCD, prioritising comparative risk and interpretable incidence; recurrence and associated clinical factors were secondary outcomes.
Methods
Primary clinical studies published between 1 January 2000 and 30 June 2025 were identified through targeted biomedical index, publisher-record and citation searching. Fifteen individually logged candidate reports were assessed; twelve original studies with clinical VTE data met the review criteria. Published denominators, effect estimates and study methods were compared narratively using PRISMA 2020 and SWiM reporting principles. Meta-analysis was not performed.
Results
Among 1,523 adolescents and adults with SCD, first-VTE incidence was 5.2 per 1,000 person-years (95% CI 3.8–6.9). A California cohort reported 696 incident cases among 6,237 patients (11.2%). Pregnancy-related VTE was recorded in 720/6,388 people with SCD (11.3%) versus 202/17,110 controls (1.2%; reported OR 10.6, 95% CI 9.1–12.5). Paediatric cohorts reported 181/10,454 (1.7%) and 12/414 (2.9%) events. Greater disease severity, central venous catheters and pregnancy were recurrently associated with VTE; recurrence and mortality also carried a substantial burden.
Conclusion
The available observational evidence indicates an important VTE burden in SCD, especially in particular adult and pregnancy populations. Interpretation depends on whether the denominator is patients, hospital admissions, person-time or patients surviving a prior event. Heterogeneous designs and incomplete ascertainment of the full literature limit the precision and generalisability of any single risk estimate.
Zitieren
APA
Alanazi, N. A., & Alqarni, S. A. (2026). Sickle Cell Disease and Risk of Venous Thromboembolism: A Systematic Review. Adolescência e Saúde, 1239-1253. https://doi.org/10.67440/ahj.vi.3148
Vancouver
Alanazi NA, Alqarni SA. Sickle Cell Disease and Risk of Venous Thromboembolism: A Systematic Review. Adolescência e Saúde. 2026:1239-1253. doi:10.67440/ahj.vi.3148
BibTeX
@article{Alanazi2026,
author = {Alanazi, Nader Awad and Alqarni, Sami Ahmad},
title = {Sickle Cell Disease and Risk of Venous Thromboembolism: A Systematic Review},
journal = {Adolescência e Saúde},
year = {2026},
pages = {1239--1253},
doi = {10.67440/ahj.vi.3148}
}
EUVIMED